CytoSite BioPharma's Debt Round

CytoSite BioPharma raised a round of funding on December 18, 2017.

CytoSite BioPharma is developing solutions to predict and monitor response to immuno-oncology therapy.…

Articles about CytoSite BioPharma's Debt Round: